Literature DB >> 11325992

Comparison of results generated by serotyping, pulsed-field restriction analysis, ribotyping, and repetitive-sequence PCR used to characterize penicillin-resistant pneumococci from the United States.

W M Dunne1, K S Kehl, C A Holland-Staley, A B Brueggemann, M A Pfaller, G V Doern.   

Abstract

One hundred forty-seven isolates of Streptococcus pneumoniae with high-level penicillin resistance collected during a national surveillance program in the United States were characterized by serotyping, pulsed-field restriction analysis, ribotyping, and repetitive-sequence (BOX element) PCR. The results generated by each method were compared by frequency of association to examine whether relationships existed between the various typing methods and statistically to determine association with the geographic source of the isolate or the age of the patient from whom the isolate was obtained. When the data were examined by pairwise analysis of individual strain classifications produced by each typing method, no statistically significant relationships between strain type, geographic location, or patient age were identified, suggesting that distinct clones of penicillin-resistant S. pneumoniae have been widely distributed throughout the United States. However, we did observed shared expression of two or three typing markers at a high frequency (>50%) among clusters of strains, indicating a certain level of concordance between the various typing methods used to classify penicillin-resistant S. pneumoniae.

Entities:  

Mesh:

Year:  2001        PMID: 11325992      PMCID: PMC88027          DOI: 10.1128/JCM.39.5.1791-1795.2001

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  14 in total

1.  Comparative evaluation of an automated ribotyping instrument versus pulsed-field gel electrophoresis for epidemiological investigation of clinical isolates of bacteria.

Authors:  R J Hollis; J L Bruce; S J Fritschel; M A Pfaller
Journal:  Diagn Microbiol Infect Dis       Date:  1999-08       Impact factor: 2.803

2.  Analysis of clonal relationships among isolates of Shigella sonnei by different molecular typing methods.

Authors:  P Y Liu; Y J Lau; B S Hu; J M Shyr; Z Y Shi; W S Tsai; Y H Lin; C Y Tseng
Journal:  J Clin Microbiol       Date:  1995-07       Impact factor: 5.948

3.  Prevalence of antimicrobial resistance among respiratory tract isolates of Streptococcus pneumoniae in North America: 1997 results from the SENTRY antimicrobial surveillance program.

Authors:  G V Doern; M A Pfaller; K Kugler; J Freeman; R N Jones
Journal:  Clin Infect Dis       Date:  1998-10       Impact factor: 9.079

4.  Novel BOX repeat PCR assay for high-resolution typing of Streptococcus pneumoniae strains.

Authors:  A van Belkum; M Sluijuter; R de Groot; H Verbrugh; P W Hermans
Journal:  J Clin Microbiol       Date:  1996-05       Impact factor: 5.948

Review 5.  Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing.

Authors:  F C Tenover; R D Arbeit; R V Goering; P A Mickelsen; B E Murray; D H Persing; B Swaminathan
Journal:  J Clin Microbiol       Date:  1995-09       Impact factor: 5.948

6.  Clonal relationships among high-level penicillin-resistant Streptococcus pneumoniae in the United States.

Authors:  G V Doern; A B Brueggemann; M Blocker; M Dunne; H P Holley; K S Kehl; J Duval; K Kugler; S Putnam; A Rauch; M A Pfaller
Journal:  Clin Infect Dis       Date:  1998-10       Impact factor: 9.079

7.  Comparison of different PCR approaches for characterization of Burkholderia (Pseudomonas) cepacia isolates.

Authors:  P Y Liu; Z Y Shi; Y J Lau; B S Hu; J M Shyr; W S Tsai; Y H Lin; C Y Tseng
Journal:  J Clin Microbiol       Date:  1995-12       Impact factor: 5.948

8.  Genetic analysis of clinical isolates of Streptococcus pneumoniae with high-level resistance to expanded-spectrum cephalosporins.

Authors:  T J Coffey; M Daniels; L K McDougal; C G Dowson; F C Tenover; B G Spratt
Journal:  Antimicrob Agents Chemother       Date:  1995-06       Impact factor: 5.191

9.  Use of PCR to study epidemiology of Serratia marcescens isolates in nosocomial infection.

Authors:  P Y Liu; Y J Lau; B S Hu; J M Shir; M H Cheung; Z Y Shi; W S Tsai
Journal:  J Clin Microbiol       Date:  1994-08       Impact factor: 5.948

10.  Comparative study of five different DNA fingerprint techniques for molecular typing of Streptococcus pneumoniae strains.

Authors:  P W Hermans; M Sluijter; T Hoogenboezem; H Heersma; A van Belkum; R de Groot
Journal:  J Clin Microbiol       Date:  1995-06       Impact factor: 5.948

View more
  5 in total

1.  Molecular characterization of hand flora and environmental isolates in a community setting.

Authors:  Preeti Pancholi; Mimi Healy; Tracy Bittner; Renee Webb; Fan Wu; Allison Aiello; Elaine Larson; Phyllis Della Latta
Journal:  J Clin Microbiol       Date:  2005-10       Impact factor: 5.948

2.  Genetic relatedness of levofloxacin-nonsusceptible Streptococcus pneumoniae isolates from North America.

Authors:  Crystal N Johnson; William H Benjamin Jr; Stephen A Moser; Susan K Hollingshead; Xiaotian Zheng; Marilyn J Crain; Moon H Nahm; Ken B Waites
Journal:  J Clin Microbiol       Date:  2003-06       Impact factor: 5.948

3.  Phenotypic and genotypic characterization of invasive Streptococcus pneumoniae clinical isolates.

Authors:  Abdulaziz M Al-Swailem; Ashraf A Kadry; Soliman I Fouda; Atef M Shibl; Omar H Shair
Journal:  Curr Ther Res Clin Exp       Date:  2004-09

4.  Penicillin susceptibility and epidemiological typing of invasive pneumococcal isolates in the Republic of Ireland.

Authors:  D Bennett; B Lennon; H Humphreys; M Cafferkey
Journal:  J Clin Microbiol       Date:  2003-08       Impact factor: 5.948

5.  Evaluation and selection of tandem repeat loci for Streptococcus pneumoniae MLVA strain typing.

Authors:  Jean-Louis Koeck; Berthe-Marie Njanpop-Lafourcade; Sonia Cade; Emmanuelle Varon; Lassana Sangare; Samina Valjevac; Gilles Vergnaud; Christine Pourcel
Journal:  BMC Microbiol       Date:  2005-11-16       Impact factor: 3.605

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.